Market Analysis — GROVE CITY MEDICAL CENTER
PA market | 3 hospitals | HHI: 4,595 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
3
Hospitals in Market
227
Total Beds
$0.2B
Market Revenue
Concentrated
HHI: 4,595
None
Moat Rating (2/10)
#2
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share29.6%
Top 3 Concentration100.0%
Network Density1.32
Margin vs Market-0.0%
Bed Util vs Market-52.8%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The PA market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 4,595).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full PA market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| SHARON REGIONAL HEALTH SYSTEM | 150 | $116M | 60.1% | 66.1% |
| EDGEWOOD SURGICAL HOSPITAL | 10 | $20M | 10.3% | 4.4% |
Regional Payer Mix
■ Medicare 32%■ Medicaid 6%■ Commercial 62%